Lillian Skidmore

This inventor holds 13 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Biopharmaceutical Innovations. Top assignees: Ambrx, Inc., Elanco US Inc.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lillian Skidmore. Retrieved from https://idiyas.com/inventor/lillian-skidmore

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 6)

% Patents Active = 92.3

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 45(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

FGF-21 Polypeptides

Dolastatin Derivatives

Porcine Interferon

Bovine G-CSF

Non-Natural Amino Acids

Modified Insulin

Nucleic Acids

Polypeptide Compositions

Methods of Treatment

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12653897 - PEGYLATED PORCINE INTERFERON AND METHODS OF USE THEREOF (2026-06-16),

2. 12622944 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2026-05-12),

3. 11993637 - Modified FGF-21 polypeptides with non-naturally encoded amino acids (2024-05-28),

4. 11542310 - Modified bovine G-CSF polypeptides and their uses (2023-01-03),

5. 11420999 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2022-08-23),

6. 10961291 - Modified FGF-21 polypeptides and their uses (2021-03-30),

7. 10960080 - Pegylated porcine interferon and methods of use thereof (2021-03-30),

8. 10954270 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2021-03-23),

9. 10377805 - Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses (2019-08-13),

10. 9975936 - Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids (2018-05-22),

11. 9796754 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2017-10-24),

12. 9517273 - Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids (2016-12-13),

13. 8946148 - Modified insulin polypeptides and their uses (2015-02-03),

Title: The Innovative Journey of Lillian Skidmore

Introduction: Lillian Skidmore, a pioneering inventor based in San Diego, CA, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Lillian Skidmore's latest patents focus on advancements in renewable energy technologies, particularly in the development of solar-powered devices for sustainable living.

Career Highlights: With a career spanning over two decades, Lillian Skidmore has established herself as a leading figure in the tech industry, known for her creativity and problem-solving skills. She has received numerous awards for her innovative work.

Collaborations: Throughout her career, Lillian Skidmore has collaborated with top research institutions and universities to further her research and bring her inventions to life. Her partnerships have led to the successful commercialization of several groundbreaking technologies.

Conclusion: Lillian Skidmore's passion for innovation and dedication to creating a more sustainable future have solidified her reputation as a trailblazing inventor in the tech world. Her work continues to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.